Atlas Trials

Efficacy and Safety of Aflibercept as Mono-therapy in Treat and Extend Regimen for DME Patients in Taiwan

Clinical trial NCT04288232 · COMPLETED

Trial details

NCT number
NCT04288232
Sponsor
Taipei Veterans General Hospital, Taiwan
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Center-involved Diabetic Macular Edema
Start date
2015-08-31
Primary completion
2017-11-16
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.